NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Temasek-Backed Manipal Health Enterprises Ltd Prepares for $1.1 Billion IPO Amid India's Sluggish IPO Market

Temasek-backed Manipal Health Enterprises Ltd has begun meeting institutional investors for its planned $1.1 billion initial public offering (IPO), according to three people aware of the matter. The company is expected to receive regulatory approval in the coming weeks, paving the way for a share sale between June-end and mid-July.

This development is significant, given India's IPO market has been largely dormant for several months due to the West Asia crisis, which has drained liquidity from emerging markets. A successful IPO for Manipal Health could potentially set the stage for other large IPOs in the market.

As one of the biggest share sales in India's healthcare sector, Manipal Health's IPO plans to raise up to ₹8,000 crore in primary capital, while its investors sell over 43.2 million shares. The Bengaluru-based company filed its draft red herring prospectus on 23 March.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

CompanyPlanned IPO Size (₹ crore)
Manipal Health Enterprises Ltd8,000
Apollo HospitalsNot specified
Aster CareNot specified

Manipal Health, founded by Ranjan Pai in 2010, focuses on key areas such as cardiology, oncology, transplants, neurosciences, orthopaedics, emergency, and critical care. The company's expansion accelerated with the acquisition of Columbia Asia's India operations for ₹2,100 crore in 2021 and Vikram Hospital for ₹350 crore in 2021. Manipal Health also took controlling stakes in AMRI Hospitals for around ₹2,300 crore in 2023, Medica Synergie for up to ₹1,400 crore in 2024, and acquired Sahyadri Hospitals from the Ontario Teachers' Pension Plan in July 2025 for around ₹6,400 crore.

In April 2023, Temasek acquired a 41% stake in the company for more than $2 billion, valuing it at nearly $4.8 billion or ₹40,000 crore. Manipal Education and Medical Group Pvt. Ltd retains around 31% of the company, with TPG holding around 10-11%. A Manipal spokesperson declined to comment.

Manipal Health's network of hospitals extends across cities such as Bangalore, Mangalore, Mysore, Vijayawada, Salem, Dwarka, Palamvihar, Goa, Jaipur, Ghaziabad, Patiala, Pune, and Kolkata. At the end of 2025, it operated 49 multi-specialty hospitals with nearly 12,600 operating beds (owned and managed) across India.

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

According to an India Ratings credit rating report in December 2025, Manipal's consolidated revenue grew 34% year-on-year to ₹8,242 crore in FY25 and ₹4,721 crore in 1HFY26. Its earnings before interest, tax, depreciation, and amortization (Ebitda) grew to ₹2,127 crore as against ₹1,683 crore in FY24 and ₹1,251 crore in 1HFY2026.

Investor Takeaway

Investors should monitor the progress of Manipal Health's IPO as it may set a precedent for other large IPOs in the Indian market.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.